Please use this identifier to cite or link to this item:
DC FieldValue
dc.titleNovel mutation in HTRA1 in a family with diffuse white matter lesions and inflammatory features
dc.contributor.authorZiaei, A.
dc.contributor.authorXu, X.
dc.contributor.authorDehghani, L.
dc.contributor.authorBonnard, C.
dc.contributor.authorZellner, A.
dc.contributor.authorNg, A.Y.J.
dc.contributor.authorTohari, S.
dc.contributor.authorVenkatesh, B.
dc.contributor.authorHaffner, C.
dc.contributor.authorReversade, B.
dc.contributor.authorShaygannejad, V.
dc.contributor.authorPouladi, M.A.
dc.identifier.citationZiaei, A., Xu, X., Dehghani, L., Bonnard, C., Zellner, A., Ng, A.Y.J., Tohari, S., Venkatesh, B., Haffner, C., Reversade, B., Shaygannejad, V., Pouladi, M.A. (2019). Novel mutation in HTRA1 in a family with diffuse white matter lesions and inflammatory features. Neurology: Genetics 5 (4) : 345. ScholarBank@NUS Repository.
dc.description.abstractObjective To investigate the possible involvement of germline mutations in a neurologic condition involving diffuse white matter lesions. Methods The patients were 3 siblings born to healthy parents. We performed homozygosity mapping, whole-exome sequencing, site-directed mutagenesis, and immunoblotting. Results All 3 patients showed clinical manifestations of ataxia, behavioral and mood changes, premature hair loss, memory loss, and lower back pain. In addition, they presented with inflammatory-like features and recurrent rhinitis. MRI showed abnormal diffuse demyelination lesions in the brain and myelitis in the spinal cord. We identified an insertion in high-temperature requirement A (HTRA1), which showed complete segregation in the pedigree. Functional analysis showed the mutation to affect stability and secretion of truncated protein. Conclusions The patients’ clinical manifestations are consistent with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL; OMIM #600142), which is known to be caused by HTRA1 mutations. Because some aspects of the clinical presentation deviate from those reported for CARASIL, our study expands the spectrum of clinical consequences of loss-of-function mutations in HTRA1. Copyright © 2019 The Author(s).
dc.publisherLippincott Williams and Wilkins
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.sourceScopus OA2019
dc.contributor.departmentDEPT OF PAEDIATRICS
dc.contributor.departmentDEPT OF PHYSIOLOGY
dc.description.sourcetitleNeurology: Genetics
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1212_NXG_0000000000000345.pdf521.95 kBAdobe PDF




checked on Jan 25, 2023

Page view(s)

checked on Jan 26, 2023

Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons